Suven Life Sciences MD, chairman, board of directors and AGM
NSE: SUVENBSE: 530239Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹268.20.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7,385 Cr806th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- −100.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- −63.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 10,72,06841.2% delivered
Suven Life Sciences board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorVENKATESWARLU JASTI
- Company Secretary and Compliance OfficerKandari Sangeetha Laxmi
6 directors3 independent2 executive1 non-executive
- VENKATESWARLU JASTI · Chairperson and managing directorExecutive · joined Mar 1989 · reappointed Nov 2024 · 2 listed boards · 1 as independent · 2 committee seats
- SUDHARANI JASTIExecutive · joined Mar 1989 · reappointed Nov 2025 · 1 listed board
- SEYED EHTESHAM HASNAINNon-executive · joined Apr 2010 · reappointed Aug 2023 · 1 listed board
- SANTANU MUKHERJEEIndependent · joined May 2018 · reappointed May 2023 · 97 months as independent · 4 listed boards · 4 as independent · 5 committee seats, 3 as chair
- ANANTHASAI PADMAJA JASTHIIndependent · joined Nov 2018 · reappointed Nov 2023 · 91 months as independent · 1 listed board · 1 as independent · 2 committee seats
- VAJJA SAMBASIVA RAOIndependent · joined Jan 2024 · reappointed Jan 2024 · 29 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 13 May 20266 of 6 present3 independent · 67 days in between
- 6 Mar 20265 of 6 present2 independent · 35 days in between
- 29 Jan 20265 of 6 present2 independent
Audit Committee
Chair SANTANU MUKHERJEE
ANANTHASAI PADMAJA JASTHI, VAJJA SAMBASIVA RAO
- 13 May 20263 of 3 present3 independent · 103 days in between
- 29 Jan 20262 of 3 present2 independent
Nomination and remuneration committee
Chair SANTANU MUKHERJEE
SEYED EHTESHAM HASNAIN, ANANTHASAI PADMAJA JASTHI, VAJJA SAMBASIVA RAO
- 22 Jun 20264 of 4 present3 independent · 39 days in between
- 13 May 20264 of 4 present3 independent · 103 days in between
- 29 Jan 20263 of 4 present3 independent
Stakeholders Relationship Committee
Chair VAJJA SAMBASIVA RAO
ANANTHASAI PADMAJA JASTHI, VENKATESWARLU JASTI
- 29 Jan 20262 of 3 present1 independent
Risk Management Committee
Chair VENKATESWARLU JASTI
SANTANU MUKHERJEE, VAJJA SAMBASIVA RAO, MOHAN KUMAR MALLARAPU
- 13 May 20264 of 4 present2 independent
Corporate Social Responsibility Committee
Chair VAJJA SAMBASIVA RAO
SEYED EHTESHAM HASNAIN, VENKATESWARLU JASTI, ANANTHASAI PADMAJA JASTHI
- 13 May 20264 of 4 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- KARVY & Co.Peer-review certificate valid to Apr 2028
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Suven Life Sciences AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Suven Life Sciences dividend history
Annual general meeting, 25 Aug 2026
69,900 shareholders on the register on 18 Aug 2026; present: 6 promoters and 146 others; votes counted by D RENUKA / D RENUKA.The company's voting result (opens in a new tab)
- Adoption of Financial StatementsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 76.66% · promoters 100.00% · institutions 88.54% · other public 27.36%
- To appoint a director in place of Prof. Seyed E Hasnain ((DIN: 02205199) who retires by rotation, and being eligible, offers himself for re-appointmentOrdinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.01% · other public 0.17%
Turnout: all 76.66% · promoters 100.00% · institutions 88.54% · other public 27.36%
- To Approve the Related Party Transaction relating to the Appointment of Dr. Madhavi Jasti, MD, to an Office or Place of Profit in Overseas Wholly Owned Subsidiaries of the CompanyOrdinaryPromoters have an interest in it99.83% for0.17% against
Against: promoters 0.00% · institutions 0.67% · other public 0.03%
Turnout: all 11.18% · promoters 0.00% · institutions 88.54% · other public 27.36%
- To re-appoint Dr. Vajja Sambasiva Rao (DIN: 09233939) as an Independent Director of the CompanSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 76.66% · promoters 100.00% · institutions 88.54% · other public 27.36%
- To Approve the Variation in the Utilization of Funds raised through Preferential IssueSpecial99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.17%
Turnout: all 76.66% · promoters 100.00% · institutions 88.54% · other public 27.36%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 22 Aug 2025, 3 resolutions
66,951 shareholders on the register on 15 Aug 2025; present: 6 promoters and 54 others; votes counted by D RENUKA / D RENUKA.The company's voting result (opens in a new tab)
- Adoption of Financial StatementsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 68.49% · promoters 100.00% · institutions 0.77% · other public 3.92%
- To appoint Smt. Sudharani Jasti (DIN: 00277998), as a Director liable to retire by rotationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 2.87% · other public 0.15%
Turnout: all 67.81% · promoters 99.00% · institutions 0.77% · other public 3.92%
- To appoint Secretarial Auditors of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.05%
Turnout: all 68.49% · promoters 100.00% · institutions 0.77% · other public 3.92%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 5 Jun 2025, 3 resolutions
65,415 shareholders on the register on 29 May 2025; present: 6 promoters and 69 others; votes counted by D RENUKA / D RENUKA.The company's voting result (opens in a new tab)
- Increase of Authorized Share Capital and consequent alteration of the Memorandum of Association of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 72.87% · promoters 100.00% · institutions 5.70% · other public 8.83%
Issue of up to 6,40,02,999 (Six Crore Forty Lakh Two Thousand Nine Hundred and Ninety-Nine) warrants each convertible into, or exchangeable for, one equity shares of the Company within the period of 18 (eighteen months) in accordance with the applicable law (“Warrants”) to the Promoter Group entity of the Company and certain identified non promoter persons / entitiesMoreLess
Special99.95% for0.05% againstAgainst: promoters 0.00% · institutions 95.53% · other public 0.02%
Turnout: all 72.87% · promoters 100.00% · institutions 5.70% · other public 8.83%
- To Re-appoint Smt. Sudharani Jasti (DIN: 00277998) as a Whole-time DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 72.17% · promoters 99.00% · institutions 5.70% · other public 8.82%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 2 Aug 2024, 3 resolutions
Present: 6 promoters and 71 others.The company's voting result (opens in a new tab)
- Adoption of Financial StatementsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.15%
Turnout: all 71.64% · promoters 99.00% · institutions 20.40% · other public 6.13%
- To appoint Shri Venkateswarlu Jasti (DIN: 00278028) as a Director liable to retire by rotationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.15%
Turnout: all 71.64% · promoters 99.00% · institutions 20.40% · other public 6.13%
- To re-appoint Shri Venkateswarlu Jasti (nDIN: 00278028) as Managing DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.15%
Turnout: all 71.64% · promoters 99.00% · institutions 20.40% · other public 6.13%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 5 Mar 2024, 1 resolution
The company's voting result (opens in a new tab)
- TO APPOINT DR. VAJJA SAMBASIVA RAO (DIN: 09233939) AS AN INDEPENDENT DIRECTORSpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.26%
Turnout: all 72.66% · promoters 100.00% · institutions 87.10% · other public 5.87%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 5 Aug 2023, 4 resolutions
Present: 6 promoters and 57 others.The company's voting result (opens in a new tab)
- Adoption of Financial StatementsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.15%
Turnout: all 71.95% · promoters 100.00% · institutions 56.75% · other public 6.88%
- To appoint Shri. Seyed Ehtesham Hasnain, (DIN: 02205199) as a Director liable to retire by rotationOrdinary99.53% for0.47% against
Against: promoters 0.00% · institutions 99.90% · other public 0.20%
Turnout: all 71.95% · promoters 100.00% · institutions 56.75% · other public 6.88%
- To re-appoint Shri Santanu Mukherjee (DIN: 07716452) as an Independent DirectorSpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.22%
Turnout: all 71.95% · promoters 100.00% · institutions 56.75% · other public 6.88%
- To re-appoint Smt. Ananthasai Padmaja Jasthi (DIN: 07484630) as an Independent DirectorSpecial99.53% for0.47% against
Against: promoters 0.00% · institutions 99.90% · other public 0.24%
Turnout: all 71.95% · promoters 100.00% · institutions 56.75% · other public 6.88%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 4 Aug 2022, 6 resolutions
Present: 5 promoters and 60 others.The company's voting result (opens in a new tab)
To receive, consider and adopt the auditednstandalone and consolidated financial statement ofnthe Company for the financial year ended Marchn31, 2022 together with the Reports of the Boardnof Directors and the Auditor’s thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 67.53% · promoters 100.00% · institutions 53.60% · other public 6.59%
- To appoint Smt. Sudharani Jasti (DIN 00277998) as a Director liable to retire by rotationOrdinary99.96% for0.04% against
Against: promoters 0.00% · institutions 8.64% · other public 0.10%
Turnout: all 67.53% · promoters 99.99% · institutions 53.60% · other public 6.59%
- To appoint Statutory Auditors and to fix their remunerationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 67.53% · promoters 100.00% · institutions 53.60% · other public 6.59%
- Increase of Authorized Share Capital and consequent alteration of the Memorandum of Association of the companyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 67.53% · promoters 100.00% · institutions 53.60% · other public 6.59%
- To approve modification of Material Related Party Transaction(s)OrdinaryPromoters have an interest in it88.93% for11.07% against
Against: promoters 0.00% · institutions 100.00% · other public 0.17%
Turnout: all 2.55% · promoters 0.00% · institutions 53.60% · other public 6.59%
- Re-appointment of Smt. Sudharani Jasti (DIN 00277998) as a Whole-time DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 67.53% · promoters 99.99% · institutions 53.60% · other public 6.59%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 6 Aug 2021, 2 resolutions
Present: 6 promoters and 62 others.The company's voting result (opens in a new tab)
Adoption of Audited Financial Statements (both Standalone and Consolidated Financial Statements) for the financial year ended March 31, 2021 and reports of the Board of Directors and the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 62.35% · promoters 100.00% · institutions 41.94% · other public 5.15%
- To appoint Shri Venkateswarlu Jasti, (DIN: 00278028) as a Director liable to retire by rotationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 62.35% · promoters 100.00% · institutions 41.94% · other public 5.15%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 22 Aug 2025, 2 fund houses
- Adoption of Financial Statements2 for0 against
- To appoint Smt. Sudharani Jasti (DIN: 00277998), as a Director liable to retire by rotation2 for0 against
- To appoint Secretarial Auditors of the Company2 for0 against
Mutual fund votes, meeting of 5 Jun 2025, 2 fund houses
- Increase of Authorized Share Capital and consequent alteration of the Memorandum of Association of the Company2 for0 against
Issue of up to 6,40,02,999 (Six Crore Forty Lakh Two Thousand Nine Hundred and Ninety-Nine) warrants each convertible into, or exchangeable for, one equity shares of the Company within the period of 18 (eighteen months) in accordance with the applicable law (“Warrants”) to the Promoter Group entity of the Company and certain identified non promoter persons / entitiesMoreLess
2 for0 against- To Re-appoint Smt. Sudharani Jasti (DIN: 00277998) as a Whole-time Director2 for0 against
3 earlier meetings
Mutual fund votes, meeting of 2 Aug 2024, 1 fund house
- Adoption of Financial Statements1 for0 against
- To appoint Shri Venkateswarlu Jasti (DIN: 00278028) as a Director liable to retire by rotation1 for0 against
- To re-appoint Shri Venkateswarlu Jasti (nDIN: 00278028) as Managing Director1 for0 against
Mutual fund votes, meeting of 5 Mar 2024, 2 fund houses
- TO APPOINT DR. VAJJA SAMBASIVA RAO (DIN: 09233939) AS AN INDEPENDENT DIRECTOR2 for0 against
Mutual fund votes, meeting of 5 Aug 2023, 1 fund house
- Adoption of Financial Statements1 for0 against
- To appoint Shri. Seyed Ehtesham Hasnain, (DIN: 02205199) as a Director liable to retire by rotation1 for0 against
- To re-appoint Shri Santanu Mukherjee (DIN: 07716452) as an Independent Director1 for0 against
- To re-appoint Smt. Ananthasai Padmaja Jasthi (DIN: 07484630) as an Independent Director1 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Tax disputes
Reported in the filing for the quarter to Jun 2026.
- Tax disputeIncome Tax Department ADIT(INT TAXN)-2,HYDSince 26 Mar 2025The Company appealed to appellate authority against the demand notice/order on 26-03-2025 and it is pending with authority for further process.At the filing before: Notice of Demand Under Section 156 of the Income Tax Act, 1961 in Form ITS – 7 for the assessment year 2020-21 a sum of Rs. 22.32 Lakhs.
- Tax disputeThe Company appealed to appellate authority against the demand notice/order on 26-03-2025 and it is pending with authority for further process.Since 24 Mar 2025The Company appealed to appellate authority against the demand notice/order on 24-03-2025 and it is pending with authority for further process.
At the filing before: Notices of Demand Under Section 156 of the Income Tax Act, 1961 in Form ITS – 7 for the Assessment Year (AY) 2018-19 a sum of Rs. 175.88 Lakhs and for the Assessment Year (AY) 2019-20 a sum of Rs. 193.04 Lakhs.MoreLess
- Tax disputeIncome Tax Department - National Faceless Assessment CentreSince 22 Apr 2025The Company appealed to appellate authority against the demand notice/order on 22-04-2025 and it is pending with authority for further process.At the filing before: Notices of Penalty Demand & Order Under Section 270A of the Income Tax Act, 1961 for the Assessment Year (AY) 2020-21 a sum of Rs. 225.45 Lakhs.
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Preferential IssuesJul 2025, checked by CRISIL Ratings Limited | 857.64 | Expenses towards the conduct of clinical development of molecules in research pipeline through Suven Neurosciences, Inc. an overseas wholly owned subsidiary of the Company | 400.00 | 272.43 | No |
| Preferential IssuesJul 2025, checked by CRISIL Ratings Limited | 857.64 | Expenses towards Drug Discovery Research & Development (R&D) | 130.00 | 51.87 | No |
| Preferential IssuesJul 2025, checked by CRISIL Ratings Limited | 857.64 | Expenses towards new R&D Centre with all requisite infrastructure and equipments (CAPEX) | 200.00 | 49.61 | No |
| Preferential IssuesJul 2025, checked by CRISIL Ratings Limited | 857.64 | Expenses towards General Corporate purposes | 127.64 | 35.59 | No |